Drug Type Biosimilar, Colony-stimulating factors |
Synonyms Kymun-CSF |
Target |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date BR (01 Jun 2016), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Neutropenia | BR | 01 Jun 2016 |